A detailed history of Versor Investments LP transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Versor Investments LP holds 20,900 shares of BMY stock, worth $1.11 Million. This represents 0.16% of its overall portfolio holdings.

Number of Shares
20,900
Holding current value
$1.11 Million
% of portfolio
0.16%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

BUY
$40.25 - $52.99 $841,225 - $1.11 Million
20,900 New
20,900 $867,000
Q4 2023

Feb 07, 2024

BUY
$48.48 - $57.85 $90,657 - $108,179
1,870 Added 15.94%
13,600 $697,000
Q3 2023

Nov 06, 2023

BUY
$57.89 - $64.73 $679,049 - $759,282
11,730 New
11,730 $680,000
Q3 2022

Oct 25, 2022

SELL
$0.13 - $76.84 $941 - $556,705
-7,245 Reduced 19.15%
30,579 $2.17 Million
Q2 2022

Jul 27, 2022

BUY
$72.62 - $79.98 $2.49 Million - $2.74 Million
34,273 Added 965.16%
37,824 $2.91 Million
Q1 2022

May 04, 2022

BUY
$61.48 - $73.72 $218,315 - $261,779
3,551 New
3,551 $259,000
Q3 2021

Nov 04, 2021

SELL
$59.17 - $69.31 $349,517 - $409,414
-5,907 Closed
0 $0
Q2 2021

Jul 27, 2021

SELL
$61.91 - $67.42 $135,335 - $147,380
-2,186 Reduced 27.01%
5,907 $395,000
Q1 2021

May 10, 2021

BUY
$59.34 - $66.74 $17,802 - $20,022
300 Added 3.85%
8,093 $511,000
Q4 2020

Feb 10, 2021

SELL
$57.74 - $65.43 $580,922 - $658,291
-10,061 Reduced 56.35%
7,793 $483,000
Q3 2020

Nov 03, 2020

SELL
$57.43 - $63.64 $68,916 - $76,368
-1,200 Reduced 6.3%
17,854 $1.08 Million
Q2 2020

Jul 30, 2020

BUY
$54.82 - $64.09 $1.04 Million - $1.22 Million
19,054 New
19,054 $1.12 Million
Q1 2019

May 09, 2019

SELL
$45.12 - $53.8 $474,662 - $565,976
-10,520 Closed
0 $0
Q4 2018

Feb 13, 2019

SELL
$48.76 - $63.23 $486,624 - $631,035
-9,980 Reduced 48.68%
10,520 $547,000
Q3 2018

Oct 25, 2018

BUY
$55.19 - $62.25 $1.13 Million - $1.28 Million
20,500 New
20,500 $1.27 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $113B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Versor Investments LP Portfolio

Follow Versor Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versor Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Versor Investments LP with notifications on news.